International Journal of Forestry Research / 2015 / Article / Tab 4

Research Article

Selective Herbicides for Cultivation of Eucalyptus urograndis Clones

Table 4

ANOVA/ANCOVA1   values for the percentage of Eucalyptus urograndis trees showing no or minor injury symptoms at 30, 60, and 90 days after treatment (DAT), for survival and stem volume index (SVI) at the end of the first growing season, and for five herbicides applied at two rates and two application timings over newly planted rooted cuttings of two E. urograndis clones.

FactorDependent variable
Percentage of trees with no or minor injury symptoms2SurvivalSVI3
30 DAT60 DAT90 DAT

Application timing (AT)4<0.00010.240<0.0001<0.0001<0.0001
Herbicide (herb)5<0.0001<0.0001<0.0001<0.0001<0.0001
Rate60.0800.0470.2940.9470.364
Clone70.7570.7360.6340.6660.781
AT × herb<0.00010.0240.000<0.0001<0.0001
AT × rate0.2050.0990.0730.9470.217
AT × clone0.4260.4950.8160.6660.178
Herb × rate0.5920.1020.8721.0000.134
Herb × clone0.7430.8980.9430.9440.963
Rate × clone0.6200.6260.8550.4820.495
AT × herb × rate0.7650.0690.5651.0000.386
AT × herb × clone0.1350.9780.3910.9440.216
AT × rate × clone0.5140.4050.6660.4820.931
Herb × rate × clone0.8180.3940.4690.7380.841
AT × herb × rate × clone0.8790.8020.4960.7380.495

ANCOVA was conducted for SVI; ANOVA was conducted for the other variables.
2Slight foliar chlorosis, slight foliar necrosis, and slight defoliation were considered minor injury symptoms, whereas any observed fasciculation, lateral shoot dieback, and leader dieback were not regarded as minor.
3Stem volume index (SVI) = ; GLD5 = outside bark stem diameter 5 cm above the ground; = live stem height.
4PRE weed emergence or POST weed emergence.
5Flumioxazin, imazamox, imazapic, oxyfluorfen, or sulfometuron methyl.
6Rate = low or high relative rate.
7Two ArborGen proprietary transgenetic FTE (frost tolerant eucalyptus) clones.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.